tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SE:HNSA Stock Latest News

Hansa Biopharma Announces Extraordinary General Meeting for Board Elections
Company AnnouncementsHansa Biopharma Announces Extraordinary General Meeting for Board Elections
22d ago
Hansa Biopharma AB: Promising Growth in Gene Therapy with Imlifidase Breakthrough
PremiumRatings
Hansa Biopharma AB: Promising Growth in Gene Therapy with Imlifidase Breakthrough
25d ago
Hansa Biopharma Reports Positive Trial Results for Imlifidase in DMD Gene Therapy
PremiumCompany Announcements
Hansa Biopharma Reports Positive Trial Results for Imlifidase in DMD Gene Therapy
28d ago
Hansa Biopharma Strengthens Leadership Team with Key Appointments
PremiumCompany Announcements
Hansa Biopharma Strengthens Leadership Team with Key Appointments
1M ago
Hansa Biopharma’s Phase 3 Trial: A Potential Breakthrough in Kidney Transplantation
PremiumCompany Announcements
Hansa Biopharma’s Phase 3 Trial: A Potential Breakthrough in Kidney Transplantation
1M ago
HNSA
Hansa Biopharma AB: Buy Rating Affirmed Amidst Growth Potential and Strategic Financial Moves
PremiumRatingsHansa Biopharma AB: Buy Rating Affirmed Amidst Growth Potential and Strategic Financial Moves
1M ago
Hansa Biopharma’s Earnings Call Highlights Growth and Stability
Premium
Company Announcements
Hansa Biopharma’s Earnings Call Highlights Growth and Stability
1M ago
Hansa Biopharma Strengthens Financial Position and Leadership Amidst Strong Sales Growth
Premium
Company Announcements
Hansa Biopharma Strengthens Financial Position and Leadership Amidst Strong Sales Growth
1M ago
Hansa Biopharma’s Phase 3 Study on Imlifidase: A Potential Game Changer in Kidney Transplantation
PremiumCompany Announcements
Hansa Biopharma’s Phase 3 Study on Imlifidase: A Potential Game Changer in Kidney Transplantation
1M ago
HNSA
Hansa Biopharma Appoints New Chief Medical Officer
PremiumCompany Announcements
Hansa Biopharma Appoints New Chief Medical Officer
2M ago
Hansa Biopharma to Release Q2 2025 Interim Results and Host Conference Call
PremiumCompany Announcements
Hansa Biopharma to Release Q2 2025 Interim Results and Host Conference Call
2M ago
Hansa Biopharma Reports Positive Five-Year Outcomes for Imlifidase in Kidney Transplantation
PremiumCompany Announcements
Hansa Biopharma Reports Positive Five-Year Outcomes for Imlifidase in Kidney Transplantation
2M ago
Hansa Biopharma Expands Share Capital and Voting Rights
PremiumCompany AnnouncementsHansa Biopharma Expands Share Capital and Voting Rights
2M ago
Hansa Biopharma AB’s AGM Approves Key Resolutions and Incentive Program
Premium
Company Announcements
Hansa Biopharma AB’s AGM Approves Key Resolutions and Incentive Program
2M ago
Hansa Biopharma Raises SEK 232 Million and Restructures Debt to Support Growth
Premium
Company Announcements
Hansa Biopharma Raises SEK 232 Million and Restructures Debt to Support Growth
2M ago
Hansa Biopharma Announces Directed Share Issue and Debt Restructuring
PremiumCompany Announcements
Hansa Biopharma Announces Directed Share Issue and Debt Restructuring
2M ago
Hansa Biopharma’s Imlifidase Shows Promising Developments in GBS Treatment, Earning Buy Rating from Analyst
PremiumRatings
Hansa Biopharma’s Imlifidase Shows Promising Developments in GBS Treatment, Earning Buy Rating from Analyst
2M ago
Hansa Biopharma’s CEO to Speak at BIO International Convention
PremiumCompany Announcements
Hansa Biopharma’s CEO to Speak at BIO International Convention
3M ago
Hansa Biopharma to Host Virtual Investor Event on Guillain-Barré Syndrome
PremiumCompany Announcements
Hansa Biopharma to Host Virtual Investor Event on Guillain-Barré Syndrome
3M ago
Hansa Biopharma Announces Strategic Restructuring for Enhanced Efficiency
PremiumCompany AnnouncementsHansa Biopharma Announces Strategic Restructuring for Enhanced Efficiency
3M ago
Hansa Biopharma Announces Annual General Meeting for June 2025
Premium
Company Announcements
Hansa Biopharma Announces Annual General Meeting for June 2025
3M ago
Hansa Biopharma’s Imlifidase Shows Promise in Treating Guillain-Barré Syndrome
Premium
Company Announcements
Hansa Biopharma’s Imlifidase Shows Promise in Treating Guillain-Barré Syndrome
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >